China Universal Asset Management »

Fulcrum Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $43k 12k 3.57
2024-06-30 $45k 7.3k 6.20
2024-03-31 $113k 12k 9.44
2023-12-31 $48k 7.2k 6.75
2023-09-30 $7.1k 1.6k 4.44
2023-06-30 $2.7k 810 3.30
2023-03-31 $2.4k 836 2.85
2022-12-31 $3.9k 529 7.28
2022-09-30 $4.0k 487 8.21

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Fulcrum Therapeutics

RA Capital Management
TCG Crossover Management
BlackRock
Nantahala Capital Management
Suvretta Capital Management
Vanguard Group
Adage Capital Partners GP
Morgan Stanley
Dimensional Fund Advisors
Woodline Partners
Geode Capital Management
State Street Corporation
Northern Trust
D. E. Shaw & Co
Goldman Sachs Group

View all funds holding Fulcrum Therapeutics